Search clinical trials for: Sulfonylurea (glimepiride)
Total 317 results
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Peru, Spain, United Kingdom, India, Philippines, Russian Federation, Hong Kong
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
University Hospital, Gentofte, CopenhagenCompletedMaturity-Onset Diabetes of the Young, Type 3Denmark
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusArgentina, United States, Mexico, Croatia, Austria, Romania, South Africa, Slovenia
-
SanofiCompletedType 2 Diabetes MellitusKorea, Republic of
-
Diabetes Frail LtdMerck Sharp & Dohme LLC; University of Campania "Luigi Vanvitelli"Withdrawn
-
Novo Nordisk A/SCompleted
-
Amsterdam UMC, location VUmcCompletedType 2 DiabetesNetherlands
-
TakedaTerminatedDiabetes Mellitus, Type 2United States, Poland, Bulgaria, Romania, Canada, Hungary, Slovakia
-
SanofiCompletedType 2 Diabetes MellitusKorea, Republic of
-
University of Colorado, DenverMerck Sharp & Dohme LLCCompletedCardiovascular Disease | Type 2 DiabetesUnited States
-
Sorlandet Hospital HFOslo University HospitalCompleted
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Non-Insulin-Dependent | Type 2 Diabetes Mellitus, Non Insulin Dependent
-
TakedaCompleted
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan
-
Pharmaceutical Research Unit, JordanSanofi-aventis Liban SALWithdrawn
-
TakedaCompletedDiabetes Mellitus, Type 2United States, Mexico, Guatemala
-
Pusan National University HospitalUnknownType 2 Diabetes MellitusKorea, Republic of
-
Novartis PharmaceuticalsCompletedType 2 Diabetes Mellitus (T2DM)France
-
Brigham and Women's HospitalCompleted
-
Medstar Health Research InstituteCompletedType 2 Diabetes MellitusUnited States
-
Merck Sharp & Dohme LLCCompleted
-
TakedaCompletedDiabetes MellitusUnited States
-
TakedaCompletedDiabetes MellitusUnited States, Argentina, Canada, Chile
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Israel, Malaysia, South Africa, Algeria, Lebanon, United Arab Emirates
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Argentina, India, Australia, Spain, Taiwan, France, Canada, Hungary, Mexico, Croatia, Korea, Republic of, Poland, Greece, Belgium, Brazil, Italy, Czech Republic, Romania, Slovakia, Sweden
-
Akros Pharma Inc.CompletedType 2 Diabetes MellitusUnited States
-
Brigham and Women's HospitalCompleted
-
Brigham and Women's HospitalCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Rehab WeridaCompletedDiabetes Mellitus, Type 2Egypt
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlGermany, Slovakia, Czechia, Hungary, Poland
-
Merck Sharp & Dohme LLCCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Hungary, Slovenia, Germany, Czech Republic, Poland, Slovakia
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Taiwan
-
Kyunghee University Medical CenterTakeda; Korea University Guro Hospital; Ajou University School of Medicine; Kangbuk... and other collaboratorsUnknownDiabetesKorea, Republic of
-
Brigham and Women's HospitalCompleted
-
TakedaEli Lilly and CompanyCompletedDiabetes MellitusDenmark, Iceland, Norway, Sweden
-
Damanhour UniversityTanta UniversityCompletedCoronary Artery Disease | Diabetes Mellitus, Type 2Egypt
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Bulgaria, Denmark, France, Germany, Hong Kong, Hungary, India, Ireland, Italy, Netherlands, Norway, Poland, South Africa, Sweden, United Kingdom
-
Changhua Christian HospitalCompletedType 2 Diabetes Mellitus | Proteinuria
-
University of JordanCompletedDiabetes Mellitus, Type 2Jordan
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2China, Malaysia, Vietnam
-
Yonsei UniversityRecruitingDiabetes Mellitus | Sodium-Glucose Transporter 2 Inhibitors | Cellular SenescenceKorea, Republic of
-
Astellas Pharma IncCompleted
-
AstraZenecaCompleted
-
University of LeicesterUniversity Hospitals, Leicester; University Hospital BirminghamCompletedType 2 DiabetesUnited Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Eli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2United States, Spain, Poland, Austria, Germany, Czech Republic, Russian Federation
-
Kaiser PermanentePatient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaboratorsRecruitingCardiovascular Diseases | Type 2 Diabetes MellitusUnited States